Supplements That May Help Manage Pancreatitis Risk on Ozempic (Semaglutide)

At a glance

  • Acute pancreatitis on the Ozempic label / Section 5.2, not the boxed warning [2]
  • Ozempic label if pancreatitis is suspected / Discontinue Ozempic [2]
  • GLP-1 receptor agonists vs control, 21 trials, 99,599 patients / No difference in pancreatitis [3]
  • Probiotic trial, predicted severe acute pancreatitis / Deaths 16% vs 6% [1]
  • Ozempic injection schedule / Once weekly, with or without meals [2]
  • Ozempic and oral medicines / Delays gastric emptying; caution advised [2]

Is there any supplement that prevents pancreatitis on Ozempic?

We found no trial of a supplement for preventing pancreatitis in people taking semaglutide. The pancreatitis evidence for this drug class comes from the drugs themselves. A pooled analysis of 21 randomized trials of GLP-1 receptor agonists covering 99,599 patients found no difference in pancreatitis between the drugs and controls [3]. A separate review of real-world data found no clear increase in severe events such as pancreatitis among people using liraglutide, semaglutide or tirzepatide [4].

What does the Ozempic label say about pancreatitis?

Acute pancreatitis sits in the Warnings and Precautions section, not the boxed warning; the boxed warning covers thyroid C-cell tumors [2]. The label states that acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists including Ozempic [2]. It describes the signs: persistent or severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by nausea or vomiting [2]. If pancreatitis is suspected, the label says to discontinue Ozempic and initiate appropriate management [2]. Acute and necrotizing pancreatitis also appear among postmarketing reports, where a frequency cannot be estimated from voluntary reports [2].

The label carries a separate gallbladder warning: gallbladder studies are indicated if cholelithiasis or cholecystitis is suspected [2].

What happened when a probiotic was tested in pancreatitis?

In one trial, 298 people with predicted severe acute pancreatitis were randomized to a multispecies probiotic preparation given enterally twice daily for 28 days, or to placebo [1]. Infectious complications occurred in 30% on the probiotic versus 28% on placebo [1]. Deaths were higher on the probiotic: 24 patients (16%) versus 9 (6%), a relative risk of 2.53 (95% CI 1.22 to 5.25) [1]. Nine patients on the probiotic developed bowel ischemia, eight of them fatally, versus none on placebo [1]. The investigators concluded that probiotic prophylaxis should not be given to patients with predicted severe acute pancreatitis [1].

These were people who already had acute pancreatitis, and the trial did not involve semaglutide.

Do oral supplements interact with semaglutide?

The Ozempic label says semaglutide delays gastric emptying and therefore has the potential to affect absorption of oral medications [2]. In clinical pharmacology trials, semaglutide did not affect the absorption of orally administered medications to any clinically relevant degree, and the label still says caution should be exercised when oral medications are given with it [2]. The label does not provide supplement-specific absorption findings [2].

Ozempic injection is given once weekly, at any time of day, with or without meals [2].

Frequently asked questions

Does the Ozempic label say to stop the drug for pancreatitis?
The label states that if pancreatitis is suspected, Ozempic should be discontinued and appropriate management started. It also says gallbladder studies are indicated if cholelithiasis or cholecystitis is suspected [2].
Are probiotics safe for people with severe acute pancreatitis?
In 298 patients with predicted severe acute pancreatitis, a multispecies probiotic did not reduce infectious complications, deaths were 16% versus 6% on placebo (relative risk 2.53), and 9 patients developed bowel ischemia versus none [1].
Does Ozempic change how oral supplements are absorbed?
The label says semaglutide delays gastric emptying and may affect absorption of oral medications, though in clinical pharmacology trials it did not affect absorption of oral medicines to a clinically relevant degree; it still says caution should be exercised [2].
How common is pancreatitis with GLP-1 receptor agonists?
Across 21 randomized trials and 99,599 patients, pancreatitis did not differ between GLP-1 receptor agonists and controls [3].
What are the warning signs of pancreatitis?
The label lists persistent or severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by nausea or vomiting [2].

References

  1. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
  2. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
  3. Galli M, Benenati S, Laudani C, Simeone B, Sarto G, Ortega-Paz L, et al. Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients. J Am Coll Cardiol. 2025;86(20):1805-1819. Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients
  4. Thomsen RW, Mailhac A, Løhde JB, Pottegård A. Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies. Diabetes Obes Metab. 2025;27 Suppl 2(Suppl 2):66-88. Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies
Evidence overview for Supplements That May Help Manage Pancreatitis Risk on Ozempic (Semaglutide)